0001567619-22-018617.txt : 20221019
0001567619-22-018617.hdr.sgml : 20221019
20221019165445
ACCESSION NUMBER: 0001567619-22-018617
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221017
FILED AS OF DATE: 20221019
DATE AS OF CHANGE: 20221019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Amy
CENTRAL INDEX KEY: 0001887865
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41008
FILM NUMBER: 221319108
MAIL ADDRESS:
STREET 1: 38 OUTLOOK ROAD
CITY: SWAMPSCOTT
STATE: MA
ZIP: 01907
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IO Biotech, Inc.
CENTRAL INDEX KEY: 0001865494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870909276
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
BUSINESS PHONE: 4570702980
MAIL ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
4
1
doc1.xml
FORM 4
X0306
4
2022-10-17
0
0001865494
IO Biotech, Inc.
IOBT
0001887865
Sullivan Amy
C/O IO BIOTECH, INC.
OLE MAALOES VEH 3
COPENHAGEN
G7
2200
DENMARK
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
2.55
2022-10-17
4
A
0
288152
0
A
2032-10-17
Common Stock
288152
288152
D
One-fourth of these options vest on 10/15/2023, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control.
/s/ Brian Burkavage, Attorney-in-Fact for Amy Sullivan
2022-10-19